Ann: PharmAust Investor Webinar Presentation, page-49

Morning Lastly , Bucklands question sounds legit, what did occur with that Company? It was announced, he provided the date...

Another week ahead, Last full week of March

ANZCTR Register has had no changes since October 12th 2022.. current Trial is still registered as Phase I,, so the update to a Phase II is still to be made.

	Study Type:	Interventional (Clinical Trial)
1	EstimatedEnrollment:	12 participants
2	Allocation:	N/A
3	Intervention Model:	Sequential Assignment
4	Masking:	None (Open Label)
5	Primary Purpose:	Treatment
6	Official Title:	A Phase I Tolerability, Safety, Pharmacokinetics and Preliminary Efficacy Study of Oral Monepantel in Individuals With Motor Neurone Disease
7	ActualStudy Start Date:	June 28, 2022
8	EstimatedPrimary Completion Date:	December 1, 2022
9	EstimatedStudy Completion Date:	May 1, 2023